Status:
NOT_YET_RECRUITING
The Combined Effect of the Mediterranean Diet and Intermittent Fasting on Hypertension
Lead Sponsor:
Nadide Gizem Tarakci Filiz
Collaborating Sponsors:
Medipol University
Istanbul Medipol University Hospital
Conditions:
Hypertension
Eligibility:
All Genders
40-65 years
Phase:
NA
Brief Summary
Hypertension (HT) is an important risk factor for cardiovascular diseases (CVD) and death. Approximately 16.9 million people in Turkey have HT. Nutritional habits play an important role in the develop...
Eligibility Criteria
Inclusion
- Newly diagnosed hypertension patients
- Individuals with blood pressure \>140/90 mmHg
- Individuals with a body mass index (BMI) in the range of 18.5-25 kg/m²
- Individuals aged 40-65 years
Exclusion
- Participants will be excluded if they have any of the following:
- Type 2 Diabetes Mellitus
- Type 1 Diabetes Mellitus
- Cardiovascular disease
- Liver disease
- Kidney disease
- Gastrointestinal disease
- Respiratory disease
- Psychiatric disorders
- Women who are pregnant or breastfeeding
- Severe food allergies
- Current smokers or individuals consuming alcohol regularly
- History of major surgery within the last 6 months
Key Trial Info
Start Date :
November 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2026
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT07189637
Start Date
November 1 2025
End Date
July 1 2026
Last Update
September 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medipol Mega University Hospital
Istanbul, Turkey (Türkiye), 34214